This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Abbott said Monday it has received approval to start a U.S ...
Global IVL market forecast to reach $3.8B by 2032, driven by rising calcified cardiovascular disease and adoption of ...
Shockwave Medical, Inc. SWAV recently announced two new publications that reported favorable and consistent outcomes with coronary intravascular lithotripsy (IVL) in both nodular and eccentric calcium ...
FastWave Medical, a developer in advanced intravascular lithotripsy (IVL) technology, announced the issuance of its sixth utility patent by the United States Patent and Trademark Office (USPTO). This ...
SANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
BOSTON--(BUSINESS WIRE)--AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ ...
Thai chemicals company Indorama Ventures Public Co Ltd (IVL) has continued its shopping spree in recent months with the acquisition of Sines, Portugal-based manufacturer of purified terephthalic acid, ...
While 2021 proved to be a tough year for the global economy with strong headwinds, such challenges have failed to throw chemical giant Indorama Ventures Plc (IVL) off course, thanks to the leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results